𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential effects of teriparatide on regional bone formation using 18F-fluoride positron emission tomography

✍ Scribed by Michelle L Frost; Musib Siddique; Glen M Blake; Amelia EB Moore; Paul J Schleyer; Joel T Dunn; Edward J Somer; Paul K Marsden; Richard Eastell; Ignac Fogelman


Publisher
American Society for Bone and Mineral Research
Year
2011
Tongue
English
Weight
185 KB
Volume
26
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Teriparatide increases skeletal mass, bone turnover markers, and bone strength, but local effects on bone tissue may vary between skeletal sites. We used positron emission tomography (PET) to study ^18^F‐fluoride plasma clearance (K~i~) at the spine and standardized uptake values (SUVs) at the spine, pelvis, total hip, and femoral shaft in 18 postmenopausal women with osteoporosis. Subjects underwent a 1‐hour dynamic scan of the lumbar spine and a 10‐minute static scan of the pelvis and femurs at baseline and after 6 months of treatment with 20 ¡g/day teriparatide. Blood samples were taken to derive the arterial input function and lumbar spine K~i~ values evaluated using a three‐compartment model. SUVs were calculated for the spine, pelvis, total hip, and femoral shaft. After 6 months treatment with teriparatide, spine K~i~ values increased by 24% (p= .0003), while other model parameters were unchanged except for the fraction of tracer going to bone mineral (k~3~/[k~2~ + k~3~]), which increased by 23% (p= .0006). In contrast to K~i~, spine SUVs increased by only 3% (p= .84). The discrepancy between changes in K~i~ and SUVs was explained by a 20% decrease in ^18^F^βˆ’^ plasma concentration. SUVs increased by 37% at the femoral shaft (p= .0019), 20% at the total hip (p= .032), and 11% at the pelvis (p= .070). Changes in bone turnover markers and BMD were consistent with previous trials. We conclude that the changes in bone formation rate during teriparatide treatment as measured by ^18^F^βˆ’^ PET differ at different skeletal sites, with larger increases in cortical bone than at trabecular sites. Β© 2011 American Society for Bone and Mineral Research.


πŸ“œ SIMILAR VOLUMES


Effect of ginseng pretreatment on cerebr
✍ Seok Rye Choi; Yasuhiro Magata; Hideo Saji; Ken Tajima; Haruhiro Kitano; Junji K πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 1 views

To investigate the effect of ginseng on damaged brain activity, we evaluated the cerebral metabolic rate of glucose (CMRglc) as a functional index in post-ischaemic rats and compared the results with those obtained after the administration of a ginseng extract. CMRglc was measured using high resolut

Evaluation of d-amphetamine effects on t
✍ Jogeshwar Mukherjee; Zhi-Ying Yang; Robert Lew; Terry Brown; Shara Kronmal; Malc πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 223 KB πŸ‘ 2 views

We have investigated the ability of dopamine to compete with the binding of the high affinity dopamine D 2 receptor positron emission tomography (PET) radioligand, 18 F-fallypride. In vitro dissociation of 18 F-fallypride with dopamine in rat striatal homogenates exhibited a dissociation rate, k off